ContractMerger Agreement • March 27th, 2023 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 27th, 2023 Company IndustryNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
ContractMerger Agreement • March 27th, 2023 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 27th, 2023 Company IndustryNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
ContractMerger Agreement • March 27th, 2023
Contract Type FiledMarch 27th, 2023Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights